Initiator Pharma A/S reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was DKK 10.42 million compared to DKK 13.55 million a year ago. Basic loss per share from continuing operations was DKK 0.2. Diluted loss per share from continuing operations was DKK 0.2.
For the six months, net loss was DKK 19.69 million compared to DKK 28.71 million a year ago. Basic loss per share from continuing operations was DKK 0.38. Diluted loss per share from continuing operations was DKK 0.38.